TrialPLoS neglected tropical diseases2016

Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.

Cynthia Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.